The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Hedrick Marc H since 2015.
This trader's CIK number is 1203672.
At the time of last reporting, Hedrick Marc H was the Chief Executive Officer of Plus Therapeutics, Inc.. (stock ticker symbol PSTV).
Also see all insider trading activities at Plus Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | PSTV | 0 | $0 | 0 | $0 | 159,681 | $0 |
| 2024 | PSTV | 32,510 | $59,840 | 0 | $0 | 0 | $0 |
| 2022 | PSTV | 12,500 | $8,399 | 0 | $0 | 0 | $0 |
| 2021 | PSTV | 7,183 | $15,370 | 0 | $0 | 0 | $0 |
| 2020 | PSTV | 13,700 | $30,503 | 0 | $0 | 0 | $0 |
| 2015 | PSTV | 41,200 | $14,992 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-10-01 | PSTV | Option Ex | 159,681 | .00 | 0 |
| 2024-09-10 | PSTV | Buy | 8,000 | 1.23 | 9,840 |
| 2024-05-08 | PSTV | Buy | 12,255 | 2.04 | 25,000 |
| 2024-05-08 | PSTV | Buy | 12,255 | 2.04 | 25,000 |
| 2022-06-15 | PSTV | Buy | 5,000 | .65 | 3,240 |
| 2022-04-26 | PSTV | Buy | 2,500 | .68 | 1,710 |
| 2022-04-26 | PSTV | Buy | 5,000 | .69 | 3,449 |
| 2021-10-26 | PSTV | Buy | 2,500 | 1.66 | 4,150 |
| 2021-04-30 | PSTV | Buy | 2,183 | 2.28 | 4,970 |
| 2021-03-04 | PSTV | Buy | 2,500 | 2.50 | 6,250 |
| 2020-12-10 | PSTV | Buy | 2,500 | 1.99 | 4,975 |
| 2020-11-30 | PSTV | Buy | 2,200 | 2.14 | 4,708 |
| 2020-08-12 | PSTV | Buy | 4,000 | 2.58 | 10,320 |
| 2020-06-22 | PSTV | Buy | 5,000 | 2.10 | 10,500 |
| 2015-08-28 | CYTX | Buy | 1,200 | .31 | 372 |
| 2015-08-27 | CYTX | Buy | 10,000 | .30 | 3,050 |
| 2015-08-21 | CYTX | Buy | 5,000 | .35 | 1,750 |
| 2015-08-21 | CYTX | Buy | 5,000 | .38 | 1,900 |
| 2015-08-20 | CYTX | Buy | 10,000 | .40 | 4,000 |
| 2015-08-18 | CYTX | Buy | 10,000 | .39 | 3,920 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hedrick Marc H (Chief Executive Officer of Plus Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.